Chris Martin has served as an Achieve Life Sciences director since 2026, chairing the Commercial Committee and serving on the Compensation Committee. He served as Chief Commercial Officer of Verona Pharma from January 2024 to October 2025 (when Verona was acquired by Merck & Co.), having earlier been its Senior Vice President and Vice President of Commercial. Before Verona he was Executive Director of Marketing at SK Life Science (2018-2020), Head of Marketing at Cempra (until its acquisition by Melinta Therapeutics), and spent ten years at Salix Pharmaceuticals. Mr. Martin also serves on the boards of Oruka Therapeutics (since 2025) and Edgewise Therapeutics (since 2025) and received a Bachelor of Science in Financial Management from Clemson University.